Halozyme Therapeutics reported $119.75M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 564.84M 16.77M
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Alnylam Pharmaceuticals ALNY:US $ 853.36M 72.83M
Amarin AMRN:US $ 645.32M 10.71M
Amgen AMGN:US $ 8247M 1087M
Aptinyx Inc APTX:US $ 130.76M 18.18M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Baxter International BAX:US $ 8494M 42M
Cara Therapeutics CARA:US $ 203.47M 26.99M
Cytokinetics CYTK:US $ 16.49M 51.36M
Esperion Therapeutics ESPR:US $ -304310000 34.92M
Halozyme Therapeutics HALO:US $ 119.75M 52.15M
Immunogen IMGN:US $ 68.46M 25.66M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Intra Cellular Therapies ITCI:US $ 553.59M 58.56M
Intrexon XON:US $ 159.2M 15.6M
JAZZ PHA JAZZ:US $ 4131.49M 333.8M
Mannkind MNKD:US $ -183.55M 9.93M
Minerva Neurosciences NERV:US $ 36.17M 9.2M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Peregrine Pharmaceuticals PPHM:US $ 44.64M 33.1M
Rigel Pharmaceuticals RIGL:US $ 68.11M 10.19M
United Therapeutics UTHR:US $ 3639.5M 194.1M
Vanda Pharmaceuticals VNDA:US $ 481.22M 13.59M